A new mechanism of action against an old enemy
Researchers identified corramycin as a promising candidate against Mycobacterium tuberculosis. In the laboratory, the natural compound is effective against various forms of the tuberculosis pathogen, including strains from clinical samples that are already resistant to common antibiotics.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.